PHILADELPHIA — (MAY 9, 2023) — The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the a…
PHILADELPHIA — (MAY 4, 2023) — The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill i…
PHILADELPHIA — (MARCH, 30, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Squire Servance, founder and managi…
PHILADELPHIA — (MARCH 28, 2023) — As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live produc…
MEDIA ADVISORY WHAT:The Wistar Institute and Stowers Institute for Medical Research in Kansas City Announces Friendly Super Bowl Wager between the Two Biomedical Research Institutes The Wistar Instit…
PHILADELPHIA — (FEBRUARY, 6, 2023) — In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader…
PHILADELPHIA — (Jan. 24, 2023) — The Wistar Institute, which has recently launched a $75 million programmatic campaign investing in biomedical advances, announces the appointment of Michael Criscuolo…
PHILADELPHIA — (Jan. 19, 2023) — amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663…
PHILADELPHIA — (JAN. 12, 2023) — Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the growth of the Cancer…
PHILADELPHIA — (OCTOBER 24, 2022) — The Wistar Institute, a leader in biomedical breakthroughs headquartered in Philadelphia, is one of the nation’s top drivers of innovation, research, and tech tran…
